Takeda (Belgium)

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.3389/fphys.2022.968185 Assessing fatigue and sleep in chronic diseases using physiological signals from wearables: A pilot study
https://doi.org/10.1186/s12984-024-01390-1 Evaluation of walking activity and gait to identify physical and mental fatigue in neurodegenerative and immune disorders: preliminary insights from the IDEA-FAST feasibility study
https://doi.org/10.1038/s41746-024-01386-0 Association of real life postural transitions kinematics with fatigue in neurodegenerative and immune diseases
https://doi.org/10.1111/ijcp.12248 Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study
https://doi.org/10.1159/000536568 Fatigue-Related Changes of Daily Function: Most Promising Measures for the Digital Age
https://doi.org/10.1016/j.dld.2024.12.011 Change in fatigue in patients with ulcerative colitis or Crohn's disease initiating biologic therapy
https://doi.org/10.1208/s12249-025-03076-w Unraveling the Effects of Filtration, Process Interruptions, and Post-Process Agitation on Protein Aggregation
https://doi.org/10.1109/embc40787.2023.10339956 Identification of Fatigue and Sleepiness in Immune and Neurodegenerative Disorders from Measures of Real-World Gait Variability
https://doi.org/10.1093/ecco-jcc/jjad212.0939 P809 VARIETY BEACH: Real-world treatment patterns for vedolizumab intravenous and subcutaneous maintenance dosing observed over 1 year in studies from Belgium, Austria and Switzerland
https://doi.org/10.1093/ecco-jcc/jjx180.850 P723 Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)
https://doi.org/10.1093/ecco-jcc/jjz203.728 P600 Vedolizumab dose optimisation: Findings from a Belgian registry
https://doi.org/10.1093/ecco-jcc/jjz203.731 P603 Persistence of vedolizumab maintenance therapy: Findings from a Belgian registry
https://doi.org/10.21203/rs.3.rs-2093105/v1 Robust Advanced Modeling and Scheduling System (RAMS): From Space Exploration to Real-World Biomanufacturing
https://doi.org/10.21203/rs.3.rs-4808262/v1 The Association Between Real Life-Assessed Sit-to-Stand and Stand-to-Sit Kinematics with Self-Reported Levels of Physical and Mental Fatigue in Neurodegenerative and Immune-Mediated Inflammatory Diseases
https://doi.org/10.1016/j.jval.2013.08.1888 Cost-Minimization Analysis of Ferumoxytol in the Management of Anemia in Patients with Chronic Kidney Disease in Belgium
https://doi.org/10.1380/jsssj.24.153 RHEED Electron Density at Crystal Surface.
https://doi.org/10.1380/jsssj.29.195 Elementary Processes and Dynamical Control of Friction and Lubrication at the Nanoscale-A Theoretical Approach-
https://doi.org/10.1182/blood.v128.22.5372.5372 Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry
https://doi.org/10.1093/ecco-jcc/jjy222.255 P131 Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry
https://doi.org/10.1093/ecco-jcc/jjab076.649 P527 Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn’s disease from a Belgian registry
https://doi.org/10.1093/ecco-jcc/jjac190.0703 P573 Change in fatigue in patients with Ulcerative Colitis or Crohn’s disease initiating vedolizumab or other biologic therapy: Data from Belgian registry patients
https://doi.org/10.1177/20420986251363378 Reflections, operational lessons, and practical insights from a pharmacovigilance inspection: a case example of organizational strategies for medical safety readiness
https://doi.org/10.1055/s-0044-1786908 VARIETY BEACH: Real-world data on treatment patterns for vedolizumab intravenous and subcutaneous maintenance dosing observed over 1 year in studies from Belgium, Austria and Switzerland
https://doi.org/10.1177/20552076261428155 IDEA-FAST clinical study protocol: Identifying digital end-points of fatigue, sleep quality and daytime sleepiness in N = 2000